Absci (ABSI) Other financing activities (2024 - 2026)
Absci (ABSI) reported Other financing activities of $59000.0 for Q1 2026, down 96.92% on a YoY basis from $1.9 million in Q1 2025, and down 93.0% sequentially from $843000.0 in Q4 2025.
Absci (ABSI) Other financing activities (2024 - 2026) Analysis & Trends
Absci (ABSI) has 3 years of Other financing activities data on file, last reported at $59000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 96.92% year-over-year to $59000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 67.25% YoY), and the FY2025 full-year result was $3.3 million, down 20.41% from the prior year.
- Other financing activities eased to $59000.0 in Q1 2026, from $843000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.2 million in Q4 2024 to a low of -$1.6 million in Q2 2024.
- A 3-year average of $941000.0 and a median of $647000.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities soared 106.26% in 2025 and sank 96.92% in 2026, its largest moves.
- Tracing ABSI's Other financing activities over 3 years: stood at $4.2 million in 2024, then plunged by 79.73% to $843000.0 in 2025, then tumbled by 93.0% to $59000.0 in 2026.
- Business Quant data shows ABSI's Other financing activities at $59000.0 in Q1 2026, $843000.0 in Q4 2025, and $451000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |